These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 27738335)
1. Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway. Yang F; Gong J; Wang G; Chen P; Yang L; Wang Z Oncotarget; 2016 Nov; 7(46):75165-75175. PubMed ID: 27738335 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells. He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777 [TBL] [Abstract][Full Text] [Related]
3. MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor. Yang F; Hu Y; Liu HX; Wan YJ J Biol Chem; 2015 Mar; 290(10):6507-15. PubMed ID: 25596928 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells. Zhang Y; Gong W; Dai S; Huang G; Shen X; Gao M; Xu Z; Zeng Y; He F Mol Cancer Res; 2012 Apr; 10(4):516-22. PubMed ID: 22446874 [TBL] [Abstract][Full Text] [Related]
5. ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells. Baik SH; Lee J; Lee YS; Jang JY; Kim CW Exp Mol Med; 2016 Mar; 48(3):e222. PubMed ID: 27012708 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinoma. Liu T; Shi Q; Yang L; Wang S; Song H; Wang Z; Xu X; Liu H; Zheng H; Shen Z BMC Cancer; 2021 Aug; 21(1):957. PubMed ID: 34445994 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor. Wang K; Liang Q; Wei L; Zhang W; Zhu P Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB. Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689 [TBL] [Abstract][Full Text] [Related]
9. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation. Cheng D; Deng J; Zhang B; He X; Meng Z; Li G; Ye H; Zheng S; Wei L; Deng X; Chen R; Zhou J EBioMedicine; 2018 Oct; 36():159-170. PubMed ID: 30195653 [TBL] [Abstract][Full Text] [Related]
10. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis. Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827 [TBL] [Abstract][Full Text] [Related]
11. Dual regulatory role of CCNA2 in modulating CDK6 and MET-mediated cell-cycle pathway and EMT progression is blocked by miR-381-3p in bladder cancer. Li J; Ying Y; Xie H; Jin K; Yan H; Wang S; Xu M; Xu X; Wang X; Yang K; Zheng X; Xie L FASEB J; 2019 Jan; 33(1):1374-1388. PubMed ID: 30138038 [TBL] [Abstract][Full Text] [Related]
12. miR-885-5p suppresses hepatocellular carcinoma metastasis and inhibits Wnt/β-catenin signaling pathway. Zhang Z; Yin J; Yang J; Shen W; Zhang C; Mou W; Luo J; Yan H; Sun P; Luo Y; Tian Y; Xiang R Oncotarget; 2016 Nov; 7(46):75038-75051. PubMed ID: 27738331 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression. Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267 [TBL] [Abstract][Full Text] [Related]
14. Co-targeting of IGF1R/mTOR pathway by miR-497 and miR-99a impairs hepatocellular carcinoma development. Cheng H; Xue J; Yang S; Chen Y; Wang Y; Zhu Y; Wang X; Kuang D; Ruan Q; Duan Y; Wang G Oncotarget; 2017 Jul; 8(29):47984-47997. PubMed ID: 28624790 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway. Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347 [TBL] [Abstract][Full Text] [Related]
16. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619 [TBL] [Abstract][Full Text] [Related]
17. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators. Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144 [TBL] [Abstract][Full Text] [Related]
18. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005 [TBL] [Abstract][Full Text] [Related]
20. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Huang GH; Shan H; Li D; Zhou B; Pang PF Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]